BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 4104085)

  • 21. Impact of Exercise on Hemophilia.
    Zetterberg E; Ljungkvist M; Salim M
    Semin Thromb Hemost; 2018 Nov; 44(8):787-795. PubMed ID: 30357762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of chrtmogenic activity assay in diagnosis and therapeitic monitoring of hemophlia.
    Adcock DM; Tiefenbacher S; Pruthi RK
    MLO Med Lab Obs; 2017 Feb; 49(2):8, 10, 12-4. PubMed ID: 30005473
    [No Abstract]   [Full Text] [Related]  

  • 23. Bioengineering factor Xa to treat bleeding.
    Camire RM
    Thromb Res; 2016 May; 141 Suppl 2():S31-3. PubMed ID: 27207419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consensus review of the treatment of cardiovascular disease in people with hemophilia A and B.
    Ferraris VA; Boral LI; Cohen AJ; Smyth SS; White GC
    Cardiol Rev; 2015; 23(2):53-68. PubMed ID: 25436468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peri-operative management of patients with coagulation disorders.
    Martlew VJ
    Br J Anaesth; 2000 Sep; 85(3):446-55. PubMed ID: 11103188
    [No Abstract]   [Full Text] [Related]  

  • 26. Activation pathways of the coagulation system in normal haemostasis.
    Osterud B
    Scand J Haematol; 1984 Apr; 32(4):337-45. PubMed ID: 6372076
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelets and coagulation. An update.
    Boudreaux MK
    Vet Clin North Am Small Anim Pract; 1996 Sep; 26(5):1065-87. PubMed ID: 8863391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacotherapy of hemophilia with the preparation of Lagochilus inebrians BGE].
    Akopow IE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(1):72-83. PubMed ID: 4104085
    [No Abstract]   [Full Text] [Related]  

  • 29. Targeting TFPI for hemophilia treatment.
    Peterson JA; Maroney SA; Mast AE
    Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S28-30. PubMed ID: 27207418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiologic considerations in the management of hemophilia.
    Briggs DK
    Pathobiol Annu; 1971; 1():205-14. PubMed ID: 4950380
    [No Abstract]   [Full Text] [Related]  

  • 31. Towards standardization of clot waveform analysis and recommendations for its clinical applications.
    Shima M; Thachil J; Nair SC; Srivastava A;
    J Thromb Haemost; 2013 Jul; 11(7):1417-20. PubMed ID: 23648068
    [No Abstract]   [Full Text] [Related]  

  • 32. Serpins, New Therapeutic Targets for Hemophilia.
    Aymonnier K; Kawecki C; Arocas V; Boulaftali Y; Bouton MC
    Thromb Haemost; 2021 Mar; 121(3):261-269. PubMed ID: 32987444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arthropathy in inhibitor patients: differences in the joint status.
    Hoots WK
    Semin Hematol; 2008 Apr; 45(2 Suppl 1):S42-9. PubMed ID: 18544425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.